Fiji has declared a national HIV emergency after a rapid rise in HIV diagnoses. In 2025, the country recorded 2,016 new diagnoses, while an estimated 1 in 60 adults was living with HIV. Here are the numbers behind Fiji’s growing HIV epidemic.
Moderna and Merck’s personalized mRNA melanoma vaccine is showing promising results in clinical trials. Here’s what the numbers reveal about recurrence, survival, effectiveness and the future of personalized cancer vaccines.
Artificial intelligence has taken another major step into biology. Scientists have used genome-focused AI models to design new bacteriophages that function in laboratory experiments, raising hopes for future phage therapies against resistant bacteria while also prompting important questions about biosafety and biosecurity. Learn how AI-designed viruses could affect phage therapy, antibiotic resistance and biosecurity.
The U.S. Food and Drug Administration (FDA) has approved Moderna’s first mRNA flu vaccine, mFlusiva, marking the first approval of
The University of Oxford has launched the world’s first Phase I clinical trial of a vaccine specifically designed to protect
New research reveals that Alzheimer’s disease may trigger inside brain cells far earlier than previously thought. Discover how amyloid beta disrupts vital tau proteins, causing a catastrophic breakdown in the neuron’s transport system long before widespread plaques and tangles form.
